The market value of diagnostic testing of STDs was US$65.9 billion in 2012 and, registering a healthy CAGR of 8.1% during the forecast period of 2013 to 2019, is estimated to be worth US$108.5 billion by 2019.
Albany, NY -- (SBWIRE) -- 11/19/2015 -- Sexually transmitted diseases (STDs), also called sexually transmitted infections (STIs) or venereal diseases (VDs), are caused by over 30 different viruses, bacteria, and parasites and are predominantly spread by sexual contact and sometimes by non-sexual means. Diagnostic testing for STDs becomes especially essential since they can have serious consequences on sexual and reproductive health - ranging from infertility and pelvic inflammatory diseases to AIDS and cervical cancer.
Complete Report with TOC @ http://www.mrrse.com/diagnostic-testing-stds
According to the WHO, over one million people around the world acquire an STD every day and STIs are among the top five disease categories for which adults seek medical care. The market for diagnostic testing of STDs has gained significance owing to the rising risks of undiagnosed and ultimately untreated cases of STIs.
The primary goal of this research report is to help readers understand the overall structure of the diagnostic testing of STDs market, its elements, factors that drive and restrict the growth of the market, and strategies adopted by various players to gain a dominant market share, observe and track key trends, study the behavior of consumers, and provide an analysis of the opportunities present in the market for diagnostic testing of STDs.
Get Discount on this report @ http://www.mrrse.com/checkdiscount/872
Overview of the global diagnostic testing of STDs market
The diagnostic testing of STDs market is largely driven by the growing incidences of STDs. Given this worrying fact, governments around the globe have begun implementing screening programs to diagnose STDs at an early stage and begin appropriate treatment. National screening programs are a great opportunity for POC and laboratory test providers, especially in diagnostic testing of STDs markets in the Asia-Pacific and Rest of the World regions. In addition, favorable reimbursements aimed at STD testing have also been issued, boosting the market for diagnostic testing of STDs.
On the other hand, the stigma associated with voluntary testing or client-initiated counseling and testing (CICT) of STDS is a major challenge in most countries even today. The irony is that a significant proportion of STD-infected patients are in regions that either do not have sufficient infrastructure for diagnostic testing of STDs or have no encouragement to get tested without being shamed. Apart from this, the presence of strict regulatory compliances for existing and new market players is restricting the growth of the diagnostic testing for STDs market.
Presently, North America and Europe dominate the global market owing to increased prevalence of STDs such as herpes simplex virus (HSV), chancroid, human papilloma virus (HPV), P&S syphilis, human immunodeficiency virus (HIV), gonorrhea, and chlamydia.
Companies mentioned in the research report
The key players featured in diagnostic testing for STDs market report are bioMerieux, Hologic, Inc. (Gen-Probe), Becton Dickinson & Company, Roche Holdings AG, Alere, Inc., and Danaher Corporation (Beckman Coulter).
Segmentation based on STD type
Herpes Simplex Virus (HSV) testing
Human Papilloma Virus (HPV) testing
P&S Syphilis testing
Human Immunodeficiency Virus (HIV) testing
Request a Sample Copy of the Report @ http://www.mrrse.com/sample/872
MRRSE stands for Market Research Reports Search Engine, the largest online catalog of latest market research reports based on industries, companies, and countries. MRRSE sources thousands of industry reports, market statistics, and company profiles from trusted entities and makes them available at a click. Besides well-known private publishers, the reports featured on MRRSE typically come from national statistics agencies, investment agencies, leading media houses, trade unions, governments, and embassies.